News Alerts

03 Feb 2019 | 09:45 AM UTC

Madagascar: Measles outbreak continues nationwide /update 4

Madagascar News Alert

Measles outbreak continues nationwide; at least 28,747 cases reported since October 2018

TIMEFRAME expected from 1/29/2019, 12:00 AM until 2/9/2019, 11:59 PM (Indian/Antananarivo). COUNTRY/REGION Antananarivo, Madagascar

Read all related news alert(s):

Event

According to the Ministry of Public Health, at least 28,747 confirmed or suspected cases of measles,  including 80 associated deaths, had been reported nationwide between October 2018 and late January 2019. Cases have been reported throughout the country's 22 regions. The most affected areas include Antananarivo and Ambato Boeny.

Context

In November 2018, the US Centers for Disease Control and Prevention issued a Level 1 travel health notice for Madagascar, advising all travelers to ensure they are vaccinated against measles.

Measles is a highly contagious viral disease that typically affects mostly children. It is transmitted via droplets from the nose, mouth, or throat of infected persons. Symptoms of measles are usually a high fever, which begins approximately ten to 12 days after exposure to the virus and lasts four to seven days. A runny nose, a cough, red and watery eyes, and small white spots inside the cheeks can develop in the initial stage. After several days, a rash erupts, usually on the face and upper neck. Over the course of about three days, the rash spreads, eventually reaching the hands and feet. The rash lasts for five to six days and then fades. On average, the rash occurs 14 days after exposure to the virus (within a range of seven to 18 days). A vaccine is available.

Advice

Individuals in Madagascar, particularly in Antananarivo, are advised to ensure their measles vaccination is up to date (including booster shots) and to contact their doctor with any questions or concerns. Anyone experiencing the above symptoms is urged to seek immediate medical attention.

 

Copyright and Disclaimer
GardaWorld is the owner or licensee of all intellectual property rights in the material presented on this website. All such rights are reserved. The use of this website and its material is subject to the Terms of Use and accordingly you must not use any content from this website for commercial or other analogous purposes without our consent, including but not limited to any deep-linking or framing in order to copy, distribute, display or monitor any portion of the website. If you have any questions or are interested in distributing any content from this website, Contact us for more details.

Related news